Advanced Search

Hemodynamics, Vasc. Biology & Hypertension Sec. to Kidney Dis. Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

SECTION HEADS

  • Photo of Sadayoshi Ito

    Sadayoshi Ito

    School of Medicine, Second Department of Internal Medicine, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan

  • Photo of Matthew Weir

    Matthew Weir

    Division of Nephrology, University of Maryland School of Medicine, Baltimore, MD, USA

Section Topics

  • » Blood pressure measurement & circadian rhythm
  • » Cortical blood flow, glomerular microcirculation & ultrafiltration
  • » Diabetic nephropathy
  • » Endothelial function
  • » Epidemiology
  • » Essential hypertension
  • » Genomic, proteomic & bioinformatics
  • » Medullary circulation
  • » Metabolic syndrome, diabetes & hypertension
  • » Reactive oxygen species, oxidative stress
  • » Renin-angiotensin-aldosterone system
  • » Salt & hypertension
  • » Secondary hypertension
  • » Sympathetic nerve system
  • » Therapy, clinical trial
  • » Vascular remodeling
  • » Vascular smooth muscle cell function
  • » Vasoactive peptide

LATEST EVALUATION

Overall, this is an important study because it provides guidance for a frequent clinical decision/scenario -- what formulation to use and what dose to initiate diuretics in decompensated heart failure (CHF) patients...

Marrick Kukin and Neel Chokshi, St Luke's-Roosevelt Hospitals, USA. F1000 Cardiovascular Disorders

8 Must Read

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

6
Telmisartan Exerts Renoprotective Actions via Peroxisome Proliferator-Activated Receptor-γ/Hepatocyte Growth Factor Pathway Independent of Angiotensin II Type 1 Receptor Blockade.

Kusunoki H, Taniyama Y, Azuma J, Iekushi K, ..., Iwabayashi M, Okayama K, Rakugi H, Morishita R. Hypertension. 2012 Feb; 59(2):308-16

1 Evaluation, most recent by

Alejandro Chade, University of Mississippi Medical Center, USA. F1000 Nephrology

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

Faculty of 1000